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Mariska MG Leeflang1*, Jonathan J Deeks2, Yemisi Takwoingi2 and Petra Macaskill3Abstract
In 1996, shortly after the founding of The Cochrane Collaboration, leading figures in test evaluation research
established a Methods Group to focus on the relatively new and rapidly evolving methods for the systematic
review of studies of diagnostic tests. Seven years later, the Collaboration decided it was time to develop a
publication format and methodology for Diagnostic Test Accuracy (DTA) reviews, as well as the software needed
to implement these reviews in The Cochrane Library. A meeting hosted by the German Cochrane Centre in 2004
brought together key methodologists in the area, many of whom became closely involved in the subsequent
development of the methodological framework for DTA reviews. DTA reviews first appeared in The Cochrane
Library in 2008 and are now an integral part of the work of the Collaboration.Background
Finding good evidence regarding the performance of
diagnostic tests and interpreting its value for practice is
more challenging and less straightforward than for inter-
ventions. Most diagnostic studies focus on diagnostic test
accuracy, which expresses a test’s ability to discriminate
between people with the target condition and those
without it [see Additional file 1]. However, estimates of
test accuracy often vary markedly between studies. Such
heterogeneity may reflect differences between studies
in the criterion used to define test positivity, study
design and patient characteristics as well as the place
of the test in the diagnostic pathway [1-3]. Furthermore,
a highly accurate test does not necessarily improve a
patient’s outcome [4]. Systematic reviews of diagnostic
test accuracy summarize the evidence about test accuracy.
Ideally, they also investigate why the results may vary
among studies, compare the performance of alternative
tests, and help the reader to put the evidence in a clinical
context [5,6].
In the early 1990s, several researchers led by Les Irwig
and Paul Glasziou were working on methods for the
systematic review of diagnostic test accuracy and identified
The Cochrane Collaboration as an obvious place where
health professionals looking for evidence about diagnostic
tests should be able to go. After an initial meeting at* Correspondence: m.m.leeflang@amc.uva.nl
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reproduction in any medium, provided the orthe 2nd Cochrane Colloquium in Hamilton, Ontario on
2 October 1994, the Cochrane Screening and Diagnostic
Test Methods Group was founded and formally registered
in the Collaboration in 1996. It initially focused on
identifying a common method for preparing diagnostic
test accuracy reviews.
One of their goals was to include diagnostic test accuracy
(DTA) reviews in The Cochrane Library. However, largely
because of the limited resources available, the Steering
Group of The Cochrane Collaboration decided that, in
1996, the Collaboration was not ready to include such a
methodologically challenging review type. Seven years later,
in 2003, Jon Deeks and Constantine Gatsonis persuaded
the Collaboration to revisit the question of inclusion of
DTA reviews. The Cochrane Collaboration was then ten
years old and had proven its value for decisions about
interventions, and important advances had been made
on the methodology for diagnostic test accuracy reviews.
The Collaboration decided that the time was right to plan
for the inclusion of systematic reviews of diagnostic test
accuracy studies in The Cochrane Library. A Cochrane
Diagnostic Reviews Working Group, led by Jon Deeks,
Constantine Gatsonis and Patrick Bossuyt with members
of the Methods Group, software experts, editors of
Cochrane Review Groups and interested authors was
established to plan and undertake the work required
for the Collaboration to deliver on these reviews [see
Additional file 2].
The first step involved achieving consensus on a core
method. The following year, the proposers of the Bayes’
Library (led by Matthias Egger and Daniel Pewsner),l Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Methods Group, and other international experts met
together in Freiburg, Germany, to discuss and agree on
appropriate methods for each step in a meta-analysis of
diagnostic test accuracy, including graphical displays.
The Bayes’ Library proposal was radically different in that
it considered producing a database of meta-analytical
estimates of likelihood ratios and pre-test probabilities,
which could be used for probability revision in Bayesian
diagnostic thinking. After debate, consensus was reached
on following a more standard methodology that utilised
sensitivity and specificity estimates. Following the meeting,
members of the Cochrane Screening and Diagnostic
Test Methods Group assisted Collaboration’s Information
Management Team with the development of a version
of the Collaboration’s Review Manager software including
functions necessary for DTA reviews and worked with
the Collaboration’s publisher to develop a publication
format. Unlike the software for intervention reviews, which
includes the ability to calculate and display the results
of meta-analyses of the included studies, an approach
was taken for linking the Collaboration’s software with
commercial statistical software packages that contained
the functionality necessary to fit the complex hierarchical
statistical models for meta-analysis.
The Cochrane Library was ready to register titles for
diagnostic test accuracy reviews in October 2007, with
the publication of the first Cochrane diagnostic test
accuracy review in October 2008 [7]. During this period,
members of the Cochrane Screening and Diagnostic Test
Methods Group worked not only on the development of
the above mentioned methods, but also on the develop-
ment of pilot reviews and guidance in the form of a
Handbook. Support Units were established in the United
Kingdom and The Netherlands to assist the Cochrane
Review Groups with publication preparation and processes
surrounding these reviews; a website was launched, train-
ing workshops were provided and a separate Editorial
Team was established to oversee DTA reviews [8].
In the following sections, we highlight some of the
methodological developments in diagnostic systematic
reviews that took place from the early 1990s until now,
against the background of the history outlined above.
Current challenges and possible solutions for them are
discussed, and we conclude with an overview of the
current status of these reviews within The Cochrane
Collaboration.
Early methodology
The first meta-analyses of diagnostic test accuracy were
published in the late 1980s and early 1990s and largely
followed the approaches used for intervention meta-
analyses: retrieval and selection of studies, assessing their
quality, summarizing their results in a meta-analysis,investigating heterogeneity and drawing conclusions for
example, [9,10]. However, meta-analysis of diagnostic
test accuracy was intrinsically more complex because test
accuracy measures usually come in pairs: sensitivity and
specificity; positive and negative predictive values; and
positive and negative likelihood ratios. A key consideration
is that accuracy measures depend on the threshold that
is used to define a positive test result. Sensitivity and
specificity, which are commonly reported, vary in opposite
directions as the threshold changes. An early regression
based method that did take this into account was not
straightforward to fit [10]. Another approach used the
area under the receiver operating characteristic (ROC)
curve to provide a single summary measure of accuracy
per study, thus losing information about threshold effects
[11]. A major breakthrough in the meta-analysis of diag-
nostic test accuracy was the publication of the statistical
method developed by Moses, Littenberg and colleagues,
which was straightforward to implement and also took
the threshold effect into account [12,13]. This method
was widely adopted in subsequent reviews.
The complexity of DTA reviews is not restricted to
statistical methods. Even formulating the review question
may not be straightforward because the accuracy of a test
can vary in different situations. For instance, study design
may affect estimated accuracy, and there is no ‘best’ design
analogous to the use of the randomized trial to compare
interventions. Furthermore, there is no standard ter-
minology to describe the variety of study designs used
to assess accuracy. Consequently, it is more difficult to
retrieve relevant studies from electronic databases and
the selection process is more complex. Interpretation
of summary estimates from a DTA review also requires
careful consideration because a highly accurate test in
itself will not improve the patient’s outcome. It is the
management of the patient and decisions made after
the test is administered that directly influence the
patient’s wellbeing. These more epidemiological issues
and considerations for the meta-analysis of test accuracy
studies were published in parallel with the statistical
developments [5,14]. After almost 20 years, these
guidelines [5] are still very relevant and current.Recent developments
At the time that the Cochrane Collaboration Steering
Group decided that it would consider diagnostic test
accuracy reviews, it appeared that the methods for these
reviews were well defined [15,16] and all that remained
was to reach consensus about which methods to adopt.
However, as the discussions progressed, limitations of
existing commonly used approaches became clear, and
ideas for alternative methods and further developments
were generated. These are outlined below.
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There was an increasing awareness that because tests
are used in a range of contexts, their value very much
depends on their place and role in clinical practice [17].
This also affects the interpretation and applicability of
the findings: Do the findings hold for any situations, or
do different situations cause the test to behave differently?
For example, questionnaires to determine whether elderly
patients are developing dementia may be of value in
general practice. However, when such a questionnaire
is used in a mental health clinic where patients have
many multiple symptoms in common, the questionnaire is
no longer able to distinguish between someone with
general mental impairment and someone with dementia.
Even if such a questionnaire could distinguish very
well between people with general cognitive impairment
and someone with dementia, its value may still depend
on other factors such as whether the knowledge that
someone has dementia rather than general cognitive
impairment will affect their outcomes and quality of
life. The potential consequences of a positive or negative
test result should be taken into account when interpreting
the results of a DTA review. If knowledge of the test result
does not affect further management, the value of testing
at that point may be very limited.
When formulating the review question, one should
also realize that diagnostic tests are not used in isolation
and that alternatives should be considered as well.
Therefore, Cochrane DTA reviews have also turned
their focus on the importance of comparative accuracy,
because choosing a test requires robust information about
the value it adds compared to existing alternatives.
Search and selection
Studies of the relative effects of different intervention
are relatively easy to find by searching for randomized
trials. Searching for studies of diagnostic test accuracy is
far more difficult because the study designs vary and there
is no one term that can be used to filter all diagnostic
studies. Multiple combinations of methodological terms
have been tried, resulting in the development of so called
‘methodological search filters’. However, it has become
clear that searching for diagnostic accuracy studies
involves more than filtering studies for their use of
diagnosis-related terms [18,19]. As a result, review authors
are often forced to screen thousands of retrieved article
titles in order to find a relatively small number of poten-
tially relevant studies.
Quality assessment
The first published empirical investigation of the effect
of a range of potential biases on diagnostic accuracy out-
comes was published in 2002 [20]. An overview of all
potential sources of bias and variation was published twoyears later and formed the basis of a Quality Assessment
for Diagnostic Accuracy Studies (QUADAS) tool [21,22].
This tool consisted of 14 items and has been widely
used by authors of diagnostic test accuracy reviews. A
modified form of QUADAS became the recommended
quality assessment tool for Cochrane diagnostic accuracy
reviews [23].
As the tool became more widely used, it became
apparent that it had some drawbacks such as not
distinguishing adequately between true biases and reporting
biases, and also not distinguishing between risk of bias
and issues of applicability or representativeness. In response
to these limitations, an updated version of the tool was
developed and published in 2011 [24]. This version,
which is now used for Cochrane DTA reviews, allows the
assessment of both risk of bias and concerns regarding
applicability in an explicit and transparent way.Meta-analysis
As outlined above, the statistical approach developed by
Moses and Littenberg was widely adopted as it was
straightforward to apply and understand. Alternative, but
substantially more complex statistical approaches were
published in the mid 1990s, providing a framework for
more rigorous methods taking proper account of within
study variability in sensitivity and specificity, and unex-
plained heterogeneity in test accuracy between studies.
[25,26]. These more rigorous methods are the basis
for the hierarchical models that are recommended for
Cochrane DTA reviews and that are increasingly used in
preference to the original Moses and Littenberg method.
Both of these hierarchical models use an estimate of
test sensitivity and specificity for each study. The first
model, commonly referred to as the Rutter and Gatsonis
Hierarchical Summary ROC (HSROC) model, focuses on
the estimation of a summary ROC curve that allows for
threshold effects (Figure 1A) [27]. A modification of this
approach was identified to fit this model in SAS software,
which has facilitated its adoption [28]. A second model,
commonly referred to as the bivariate model, performs a
joint meta-analysis of logit transformed sensitivity and
specificity, allowing for correlation between them across
studies, with the aim of obtaining a summary estimate for
both sensitivity and specificity (Figure 1B) [29]. Further
work on these models has demonstrated that they are
mathematically equivalent, but the different parameter-
isations affect the interpretation of covariates included
in the models [30,31].
The Rutter and Gatsonis (HSROC) model assumes that
each test is subject to a threshold effect, either explicitly
by applying a different cut-point in the case of continuous
test results, or implicitly as occurs in imaging studies.
Under the HSROC model, threshold effects between
Figure 1 Summary receiver-operating characteristic (ROC) plots showing test accuracy of cytology for detecting primary bladder
cancer [32]. A) The summary ROC curve, representing the underlying relationship between sensitivity and specificity for the test across varying
thresholds. B) The summary sensitivity and specificity and a 95% confidence region around it. The smaller oval shaped symbols in both graphs
show the individual study results, with the height of the symbol representing the number of diseased individuals and the width of the ovals
representing the number of non-diseased individuals.
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that is based on an underlying test positivity rate in each
study. If thresholds vary between studies, estimating one
overall summary pair of sensitivity and specificity is not
appropriate or readily interpretable because the sensitivity
and specificity will vary by threshold. The bivariate
model adopted by Reitsma and colleagues focuses on the
estimation of a summary pair of sensitivity and specificity
on the basis that clinicians require this information to
assess the consequences of decisions made after a test
result is known. Clearly, this approach requires that the
study specific estimates of sensitivity and specificity for
a test are obtained using a common criterion (threshold)
for test positivity for the summary estimates to have a
clear interpretation. Because of these considerations,
review authors are advised to think carefully about the
questions they aim to address in their review and the
type of test they are analyzing to guide their choice of
model [33].Future developments
With most of the basic methods now developed and
available as guidance for review authors [6,8], it is time to
consider future directions. Some ongoing developments
may make the process of preparing a systematic review of
diagnostic test accuracy easier, but other developments
may lead to greater complexity.Search and selection
Developments in text mining and machine learning
techniques may make the search and selection of studies
an easier task. These techniques may help in developing
search strategies, but their biggest advantage will probablybe in the stages of study selection The software can be
trained to recognize relevant studies from irrelevant
studies, allowing automatic filtering out of the clearly
non-relevant studies at the first selection stage. The
techniques may also be used in place of a second or
third reviewer, being more objective and perhaps also
more consistent than a human reviewer. This could
facilitate the handling of disagreements in the selection
stage.
Publication bias
In diagnostic research, not much is known about the
‘drivers’ behind publication bias. A diagnostic accuracy
study usually does not test a hypothesis and so there is
no P value for authors and publishers to influence deci-
sions about publication that are based on the statistical
significance of the results. Investigating what drives the
publication of a diagnostic study is difficult because no
formal registration of these studies exists, and because
these studies may also be done on ad-hoc basis using
pre-existing data or samples. In the light of the current
developments with regard to the ensuring publication of
each trial ever done (see www.alltrials.net), it would be
good to set similar standards for accuracy studies. Until
then, we should urge review authors to put extra effort
into finding unpublished, as well as published diagnostic
test accuracy studies. This will also help to inform factors
associated with non-publication, thereby informing the
further development of approaches for assessing potential
publication bias [34,35].
Meta-analysis
In terms of statistical methods, future developments are
likely to reflect the increasing interest in comparative
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hence, it is appropriate to evaluate the accuracy of a test
not in isolation, but relative to relevant alternative tests.
Unfortunately, studies that directly compare tests are not
common and meta-analyses to compare tests must often
rely on a set of studies that evaluated one of the tests
(test A) and a different set of studies that have evaluated
the alternative test (test B). This indirect approach would
not be acceptable in a systematic review to compare
the effectiveness of two interventions, but is common
practice when comparing tests because of the limitations
of available data. Nevertheless, developments in the
area of indirect comparisons and multiple treatment
comparison meta-analyses for intervention studies may
help to guide future methodological developments for
DTA comparative meta-analyses [36]. At present, the
routinely used models for DTA meta-analysis utilise
data on a single sensitivity and specificity pair for each
study. Hence, current models do not fully utilise all of
the available data. Some progress has been made in this
area [37], but more general and robust methods are
required.Interpretation and summary of findings
A major focus of DTA reviews is to obtain summary
estimates of test accuracy. However, knowing that a test
has a high sensitivity for instance does not tell us
whether the test will have much impact on the patient,
nor does it tell us that using this test in practice will be
beneficial for the patient, or cost-effective. Improved
accuracy is not even necessary for patient benefit to
occur because new tests may improve outcomes if they
can be used on a wider patient group, are less invasive,
or allow time-critical effective therapy to be given earlier
[38]. Although a GRADE approach for diagnostic tests
has now been developed, providing guidance on how to
translate accuracy data into a recommendation involving
patient important outcomes requires much more con-
sideration [39].Conclusions
Preparing a diagnostic test accuracy review is likely to be
very time consuming and challenging. The challenges
start at the point of question formulation. Most chapters
of the Cochrane Handbook for Diagnostic Test Accuracy
Reviews have been published and software is available to
facilitate the review process and meta-analysis. In April
2013, the titles for around Cochrane DTA reviews have
been registered. With 13 published reviews and 61
published protocols in Issue 4, 2013 of The Cochrane
Library, the DTA reviews are now an established part
of the Library and may serve as an example for the
inclusion of future new review types.Additional files
Additional file 1: Glossary. This Glossary contains the definitions for
some of the technical terms mentioned in the main text.
Additional file 2: Appendix. Contributors to the Diagnostic Test
Accuracy Working Group.
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